Hemato Webinar | Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe
the chair
1st Hemato Webinar
Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe
We are planning to hold a webinar related to an important special issue entitled “entitled Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe.”
The diagnosis of a tumour and its management are based on the confirmation of its malignancy, and on its site of origin, histotype, grade and spread throughout the body. These features are defined in the classifications of malignant tumours developed by the World Health Organization (WHO) and Union for International Cancer Control (UICC). These classifications, created to help management decisions, represent a consensus among pathologists, radiologists and clinical oncologists, and are based on epidemiological, morphological, phenotypic, and biological data. In the era of precision medicine and cancer genomics, the application of these internationally accepted classifications is considered obligatory as the starting point for cancer management. The webinar details current WHO lymphoma classification and discuss how it may change in the future, given the advances in cancer genomics.
Date: 12 January 2022
Time: 3:00pm CET | 9:00am EST | 10:00pm CST Asia
Webinar ID: 871 8579 4604
Webinar Secretariat: hemato.webinar@mdpi.com
Meet Our Speakers
Prof. Dr. Antonino Carbone
Department of Pathology, CRO Aviano - A.O. “S. Maria degli Angeli” Pordenone, Italy;
Former Chairman of Department of Pathology CRO Aviano - “S. Maria degli Angeli” Pordenone Hospital, and Scientific Director CRO Aviano.
He was a Member of WHO International Agency for Research on Cancer (IARC), Monograph Working Group on Biological Agents, Lyon 2019.
He is the Chairman of the Italian TNM Staging Committee UICC;
He is a Member of the Scientific Board of the EORTC Pathobiology Group, and Chairman of the Hematological subgroup
Editor-in-Chief of Hemato, an International Open Access Journal of Hematology
Field of interest: Lymphoma classification; Hodgkin lymphoma; non-Hodgkin lymphoma; tumor microenvironemt; HIV-associated lymphomas; EBV-associated lymphomas; KSHV/HHV8- associated lymphomas.
Methods of research: Immunohistochemistry; multiplexing immunohistochemistry; in situ hybridization; cell culture; cell lines; secretoma; digital pathology.
On Wednesday, 12 January 2022, MDPI and the Journal Hemato organized the 1st Webinar on Hemato, entitled "Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honour of Dr. Elaine S. Jaffe" and chaired by Prof. Dr. Antonino Carbone from the Department of Pathology, CRO Aviano - A.O. “S. Maria degli Angeli” Pordenone, Italy. This online seminar was held in honour of Dr. Elaine S. Jaffe, whose clinical and investigational studies have enhanced the understanding of human lymphomas. Her work has helped to define multiple entities using the principles of the REAL classification, nowadays incorporated in WHO classification of lymphomas.
In this webinar, Prof. Dr. Jude Fitzgibbon, Dr. Sam Mbulaiteye, Dr. Anna Sureda, Dr. Fina Climent, Prof. Dr. Antonino Carbone, and Dr. Elaine Jaffe discussed on some entities, including the current WHO classification, and how they may change given the advances in cancer genomics. Their presentations were followed by Q&A sessions moderated by the chair.
The webinar was offered via Zoom and required registration to attend. The full recording can be found below. In order to stay updated on the next webinars on Hemato, be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.
Special Issues in Hemato
Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe
Guest Editors: Dr. Alina Nicolae & Prof. Dr. Antonino Carbone
Deadline for manuscript submissions: 31 January 2022
Special Issues in Cancers
Novel Markers in Lymphoma
Guest Editor: Dr. Ayse U. Akarca
Deadline for manuscript submissions: 28 March 2022
Peripheral T-cell Lymphoma: From Biological Research to New Therapies
Guest Editors: Dr. Shingo Nakahata & Dr. Kazuhiro Morishita
Deadline for manuscript submissions: 31 March 2022
Recent Advances in Diagnostic and Treatment Strategies in Malignant Lymphoma
Guest Editor: Prof. Dr. Mathias Witzens-Harig
Deadline for manuscript submissions: 20 April 2022